Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.

Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.

Item
http://www.wikidata.org/entity/Q42676896
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulnessTreatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonistsSimilar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.Management of type 2 diabetes mellitus in older patients: current and emerging treatment options.Dysbiosis of urinary microbiota is positively correlated with type 2 diabetes mellitus.Evaluation of the Chinese herbal medicine Jinlida in type 2 diabetes patients based on stratification: Results of subgroup analysis from a 12-week trial.Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis.Safety and tolerability of glucagon-like peptide-1 receptor agonists: unresolved and emerging issues.Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes.Lixisenatide (Adlyxin): A Once-Daily Incretin Mimetic Injection for Type-2 Diabetes.Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.
P2860

Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.

Item
http://www.wikidata.org/entity/Q42676896
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Efficacy and safety of lixisen ...... e GetGoal phase III programme.
@en
Efficacy and safety of lixisenatide in elderly
@nl
type
label
Efficacy and safety of lixisen ...... e GetGoal phase III programme.
@en
Efficacy and safety of lixisenatide in elderly
@nl
prefLabel
Efficacy and safety of lixisen ...... e GetGoal phase III programme.
@en
Efficacy and safety of lixisenatide in elderly
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Efficacy and safety of lixisen ...... e GetGoal phase III programme.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921